Glucose News and Research

RSS

Intestinal MCT1 plays a crucial role in sex-dependent metabolic regulation

Monocarboxylate transporter 1 (MCT1) plays a crucial role in the transport of lactate, pyruvate, ketone bodies, and short-chain fatty acids (SCFA), as well as MCT1-targeted drugs in various tissues.

14 Nov 2023

New wireless biosensor technology could revolutionize healthcare

A wireless biosensor, developed by a Malmö University researcher, enables a more patient-controlled system whereby infections can be detected much earlier through smart catheters, smart diapers or wound dressings.

14 Nov 2023

Rat study suggests hemodialysis plus ketogenic diet could enhance cancer treatment

The study in Scientific Reports investigates the potential of hemodialysis (HD) to sustain elevated blood ketone levels in rats on a ketogenic diet, exploring its use as an adjunct in cancer treatment. Results show that HD maintains ketone levels while reducing glucose and insulin, suggesting a possible enhancement in cancer treatment efficacy.

13 Nov 2023

Optimal hydration post-exercise: Study compares sodium and carbohydrate levels in sports drinks for effective rehydration

In this study, researchers compared the effectiveness of sports drinks with varying carbohydrate and sodium levels for rehydrating athletes post-exercise, finding that drinks with higher sodium and lower carbohydrate content were more effective for rapid and complete rehydration. The study highlighted the importance of beverage composition in athlete recovery and hydration strategies.

13 Nov 2023

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who do not have diabetes.

13 Nov 2023

Brazzein and monellin: Safe alternatives to sugar, new research confirms

Toxicity assessments of monellin and brazzein.

10 Nov 2023

Preclinical discovery could point the way toward better treatments for type 2 diabetes

A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in type 2 diabetes, according to a new study by Weill Cornell Medicine investigators.

9 Nov 2023

How glucose restriction makes lung cancer cells more aggressive

One of the hallmarks of cancer cell development is its dependence on sugar, especially glucose, to grow and divide.

7 Nov 2023

Research brings the prospect of injection-free treatment closer for people with diabetes

A University of Alberta team has developed a new step to improve the process for creating insulin-producing pancreatic cells from a patient's own stem cells, bringing the prospect of injection-free treatment closer for people with diabetes.

7 Nov 2023

Probiotics paired with metformin could be a game-changer in type 2 diabetes control

Probiotic supplementation shows promise in managing type 2 diabetes by improving glycemic control, particularly when combined with metformin, although results vary based on probiotic composition and regimen.

6 Nov 2023

Can PTSD deteriorate women's cardiovascular and neurological health?

Whether posttraumatic stress disorder (PTSD) symptoms in civilian midlife women negatively affected their cardiovascular and neurocognitive health.

6 Nov 2023

Study probes the hidden impact of low-cal sweeteners on gut health

The research scrutinizes the impact of low- and non-calorie sweeteners on gut microbiota, suggesting potential links to glucose tolerance and insulin resistance, with varying results across studies indicating a need for more comprehensive research.

5 Nov 2023

Avocado a day may keep diabetes at bay, suggests nutritional biomarker study

New research in The Journal of Nutrition links avocado consumption with lower diabetes risk, revealing specific metabolomic biomarkers that indicate potential for reduced fasting glucose and insulin levels.

5 Nov 2023

Sotagliflozin provides kidney and heart benefits in patients with diabetes and chronic kidney disease

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are medications that lower blood sugar levels among other effects, provide kidney- and heart-related benefits to patients with and without diabetes.

3 Nov 2023

High-impact clinical trial results to be presented at ASN Kidney Week 2023

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2023 November 1–November 5.

3 Nov 2023

Study highlights safety concerns of SGLT2i in patients with diabetes and cancer

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have heart- and kidney-related benefits for patients with and without diabetes that go beyond their initial indication for lowering blood sugar levels.

2 Nov 2023

Citrus compounds show zesty promise in type 2 diabetes management

Citrus compounds show promise in type 2 diabetes management, reducing blood glucose and mitigating metabolic complications without a clear threshold in humans for bioflavonoid efficacy.

2 Nov 2023

Influence of healthy lifestyle habits on chronic disorders

The health benefits of regular exercise, a healthy diet, and adequate sleep.

2 Nov 2023

Sweet truths: Could blackcurrant and citrus extracts help prevent type 2 diabetes?

In a recent study, European researchers found that blackcurrant (BC) extracts can lower blood sugar levels immediately after meals, but higher doses aren't more effective and fruit fibers don't boost the effect. Despite limitations, the study offers new directions for researching dietary interventions in managing type 2 diabetes and blood glucose levels.

1 Nov 2023

Time-restricted eating outperforms calorie counting in weight loss for type 2 diabetes patients

In a six-month randomized clinical trial, researchers found that time-restricted eating (TRE) was more effective than daily calorie restriction for weight loss and equally effective in regulating glucose levels in adults with type 2 diabetes. The study suggests TRE could be a simpler and more easily adhered to dietary strategy for managing the condition.

31 Oct 2023

Glucose News and Research

Intestinal MCT1 plays a crucial role in sex-dependent metabolic regulation

New wireless biosensor technology could revolutionize healthcare

Rat study suggests hemodialysis plus ketogenic diet could enhance cancer treatment

Optimal hydration post-exercise: Study compares sodium and carbohydrate levels in sports drinks for effective rehydration

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

Brazzein and monellin: Safe alternatives to sugar, new research confirms

Preclinical discovery could point the way toward better treatments for type 2 diabetes

How glucose restriction makes lung cancer cells more aggressive

Research brings the prospect of injection-free treatment closer for people with diabetes

Probiotics paired with metformin could be a game-changer in type 2 diabetes control

Can PTSD deteriorate women's cardiovascular and neurological health?

Study probes the hidden impact of low-cal sweeteners on gut health

Avocado a day may keep diabetes at bay, suggests nutritional biomarker study

Sotagliflozin provides kidney and heart benefits in patients with diabetes and chronic kidney disease

High-impact clinical trial results to be presented at ASN Kidney Week 2023

Study highlights safety concerns of SGLT2i in patients with diabetes and cancer

Citrus compounds show zesty promise in type 2 diabetes management

Influence of healthy lifestyle habits on chronic disorders

Sweet truths: Could blackcurrant and citrus extracts help prevent type 2 diabetes?

Time-restricted eating outperforms calorie counting in weight loss for type 2 diabetes patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News